Atlas Trials

ACE Inhibition and Novel Cardiovascular Risk Factors

Clinical trial NCT00051389 · COMPLETED

Trial details

NCT number
NCT00051389
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiovascular DiseasesHeart DiseasesHypertension
Start date
2002-02-01
Primary completion
2007-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.